{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Lispro+insulin&page=2", "query": { "intervention": "Lispro insulin", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 156, "total_pages": 16, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Lispro+insulin&page=3&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Lispro+insulin&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-01T06:15:11.981Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00993473", "title": "6-month Comparison of Morning Lantus Versus Neutral Protamine Hagedorn Insulin in Young Children With Type 1 Diabetes", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Type 1 Diabetes Mellitus" ], "interventions": [ { "name": "Insulin glargine (HOE901)", "type": "DRUG" }, { "name": "Neutral Protamine Hagedorn (NPH) insulin", "type": "DRUG" }, { "name": "Insulin lispro", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sanofi", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "1 Year", "maximum_age": "6 Years", "sex": "ALL", "summary": "1 Year to 6 Years" }, "enrollment_count": 125, "start_date": "2009-10", "completion_date": "2011-03", "has_results": true, "last_update_posted_date": "2012-06-27", "last_synced_at": "2026-10-01T06:15:11.981Z", "location_count": 8, "location_summary": "Sacramento, California • San Diego, California • Greenwood Village, Colorado + 5 more", "locations": [ { "city": "Sacramento", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Greenwood Village", "state": "Colorado" }, { "city": "Baltimore", "state": "Maryland" }, { "city": "Buffalo", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT00993473" }, { "nct_id": "NCT02294474", "title": "Comparison of SAR342434 to Humalog as the Rapid Acting Insulin in Adult Patients With Type 2 Diabetes Mellitus Also Using Insulin Glargine", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Type 2 Diabetes Mellitus" ], "interventions": [ { "name": "SAR342434", "type": "DRUG" }, { "name": "Humalog", "type": "DRUG" }, { "name": "insulin glargine HOE901", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sanofi", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 505, "start_date": "2015-01", "completion_date": "2016-02", "has_results": true, "last_update_posted_date": "2018-01-18", "last_synced_at": "2026-10-01T06:15:11.981Z", "location_count": 51, "location_summary": "Foley, Alabama • Muscle Shoals, Alabama • Chandler, Arizona + 45 more", "locations": [ { "city": "Foley", "state": "Alabama" }, { "city": "Muscle Shoals", "state": "Alabama" }, { "city": "Chandler", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT02294474" }, { "nct_id": "NCT02443402", "title": "Sitagliptin in Non-Diabetic Patients Undergoing Cardiac Surgery", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Coronary Artery Disease" ], "interventions": [ { "name": "Sitagliptin", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Regular Human Insulin", "type": "DRUG" }, { "name": "Insulin glargine", "type": "DRUG" }, { "name": "Supplemental insulin (Insulin lispro)", "type": "DRUG" }, { "name": "Supplemental insulin (Insulin aspart)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Emory University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 68, "start_date": "2016-01", "completion_date": "2016-12", "has_results": true, "last_update_posted_date": "2018-02-06", "last_synced_at": "2026-10-01T06:15:11.981Z", "location_count": 4, "location_summary": "Atlanta, Georgia", "locations": [ { "city": "Atlanta", "state": "Georgia" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Atlanta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT02443402" }, { "nct_id": "NCT01045954", "title": "A Study of the Rules for Insulin Dosing in Patients Using Multiple Daily Injections", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Diabetes Mellitus Type 1" ], "interventions": [ { "name": "Lispro Insulin and glargine insulin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Diabetes Care Center", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 50, "start_date": "2010-01", "completion_date": "2010-10", "has_results": false, "last_update_posted_date": "2010-01-11", "last_synced_at": "2026-10-01T06:15:11.981Z", "location_count": 1, "location_summary": "Salinas, California", "locations": [ { "city": "Salinas", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01045954" }, { "nct_id": "NCT01109316", "title": "Insulin Lispro 6 Days Versus Insulin Aspart 6 Days in Pump Use", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Diabetes Mellitus, Type 1" ], "interventions": [ { "name": "Insulin lispro 2 day reservoir in-use", "type": "DRUG" }, { "name": "Insulin lispro 6 day reservoir in-use", "type": "DRUG" }, { "name": "Insulin aspart 6 day reservoir in-use", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Eli Lilly and Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "13 Years", "maximum_age": null, "sex": "ALL", "summary": "13 Years and older" }, "enrollment_count": 132, "start_date": "2010-04", "completion_date": "2011-08", "has_results": true, "last_update_posted_date": "2019-03-27", "last_synced_at": "2026-10-01T06:15:11.981Z", "location_count": 11, "location_summary": "Concord, California • Aurora, Colorado • Hollywood, Florida + 8 more", "locations": [ { "city": "Concord", "state": "California" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Hollywood", "state": "Florida" }, { "city": "West Palm Beach", "state": "Florida" }, { "city": "Idaho Falls", "state": "Idaho" } ], "official_url": "https://clinicaltrials.gov/study/NCT01109316" }, { "nct_id": "NCT02556918", "title": "Sitagliptin for Hyperglycemia in Patients With T2DM Undergoing Cardiac Surgery", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Hyperglycemia" ], "interventions": [ { "name": "Sitagliptin", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Regular Human Insulin", "type": "DRUG" }, { "name": "Insulin glargine", "type": "DRUG" }, { "name": "Supplemental insulin (Insulin lispro)", "type": "DRUG" }, { "name": "Supplemental insulin (Insulin aspart)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Emory University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 202, "start_date": "2016-01", "completion_date": "2018-11-06", "has_results": true, "last_update_posted_date": "2019-12-23", "last_synced_at": "2026-10-01T06:15:11.981Z", "location_count": 3, "location_summary": "Atlanta, Georgia", "locations": [ { "city": "Atlanta", "state": "Georgia" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Atlanta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT02556918" }, { "nct_id": "NCT01184014", "title": "Hospital Insulin Protocol Aims for Glucose Control in Corticosteroid-induced Hyperglycemia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Hyperglycemia" ], "interventions": [ { "name": "NPH insulin plus Complete Insulin Orders", "type": "DRUG" }, { "name": "Complete Insulin Orders", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "HealthPartners Institute", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 72, "start_date": "2010-08", "completion_date": "2012-08", "has_results": true, "last_update_posted_date": "2018-06-13", "last_synced_at": "2026-10-01T06:15:11.981Z", "location_count": 1, "location_summary": "Saint Louis Park, Minnesota", "locations": [ { "city": "Saint Louis Park", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT01184014" }, { "nct_id": "NCT00705536", "title": "Pharmacokinetic (PK), Pharmacodynamic (PD), and Safety Study of Subcutaneously Administered Humalog® With and Without Recombinant Human Hyaluronidase (rHuPH20)and Humulin-R® With and Without rHuPH20", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Diabetes Mellitus" ], "interventions": [ { "name": "Humalog", "type": "DRUG" }, { "name": "Humulin-R", "type": "DRUG" }, { "name": "Recombinant human hyaluronidase PH20 (rHuPH20)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Halozyme Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "MALE", "summary": "18 Years to 55 Years · Male only" }, "enrollment_count": 26, "start_date": "2007-12", "completion_date": "2008-02", "has_results": true, "last_update_posted_date": "2019-02-26", "last_synced_at": "2026-10-01T06:15:11.981Z", "location_count": 1, "location_summary": "San Antonio, Texas", "locations": [ { "city": "San Antonio", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00705536" }, { "nct_id": "NCT00442767", "title": "Post-meal Insulin Dosing With Adjuvant Pre-meal Pramlintide in Children With Type 1 Diabetes Mellitus", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Type 1 Diabetes Mellitus" ], "interventions": [ { "name": "Insulin", "type": "DRUG" }, { "name": "Pramlintide + Insulin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Montefiore Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": "21 Years", "sex": "ALL", "summary": "12 Years to 21 Years" }, "enrollment_count": 8, "start_date": "2007-02", "completion_date": "2009-02", "has_results": true, "last_update_posted_date": "2018-07-10", "last_synced_at": "2026-10-01T06:15:11.981Z", "location_count": 1, "location_summary": "The Bronx, New York", "locations": [ { "city": "The Bronx", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT00442767" }, { "nct_id": "NCT01000922", "title": "A Study Comparing the Pharmacodynamic Properties of Insulin VIAJECT™, Regular Human Insulin, and Insulin Lispro", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Diabetes Mellitus" ], "interventions": [ { "name": "Regular Human Insulin", "type": "DRUG" }, { "name": "Lispro", "type": "DRUG" }, { "name": "VIAject", "type": "DRUG" }, { "name": "VIAject 50%", "type": "DRUG" }, { "name": "VIAject/Insulin Glargine", "type": "DRUG" }, { "name": "Insulin Glargine/VIAject", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Biodel", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "19 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "19 Years to 70 Years" }, "enrollment_count": 24, "start_date": "2006-06", "completion_date": "2008-01", "has_results": false, "last_update_posted_date": "2015-07-29", "last_synced_at": "2026-10-01T06:15:11.981Z", "location_count": 1, "location_summary": "Chula Vista, California", "locations": [ { "city": "Chula Vista", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01000922" } ] }